Valuation: Cipla Limited

Market Cap 1,140B 11.83B 10.39B 9.67B 8.87B 16.66B 16.92B 115B 44.84B 560B 44.42B 43.46B 1,937B P/E 2027 *
27.4x
P/E 2028 * 22.1x
Enterprise Value 1,033B 10.73B 9.43B 8.77B 8.04B 15.11B 15.35B 104B 40.67B 508B 40.29B 39.42B 1,757B EV / Sales 2027 *
3.33x
EV / Sales 2028 * 2.9x
Free-Float
68.88%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day-0.09%
1 week-2.23%
Current month-3.82%
1 month-3.07%
3 months+7.00%
6 months+7.34%
Current year-6.74%
1 week 1,366.1
Extreme 1366.1
1,444.8
1 month 1,366.1
Extreme 1366.1
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-2.23%-10.34%+20.31% 11.83B
+1.68%+0.88%+15.95%+73.90% 48.36B
+1.52%+2.21%+61.55%+111.64% 35.8B
-0.05%-3.55%+13.07%+70.62% 11.48B
-0.09%-0.37%+37.53%+142.08% 9.01B
+0.18%+1.77%+47.40%-8.43% 6.99B
+2.15%-0.42%+13.68%+34.39% 6.7B
+0.18%-1.94%+2.41%+167.04% 6.42B
-7.92%-13.61%-33.87%-3.30% 5.3B
+0.49%-2.39%+22.37%+118.10% 4.37B
Average -0.19%-2.05%+16.98%+72.64% 14.63B
Weighted average by Cap. +0.75%-0.48%+25.28%+79.62%

Financials

2027 *2028 *
Net sales 310B 3.22B 2.83B 2.63B 2.41B 4.53B 4.6B 31.22B 12.2B 152B 12.08B 11.82B 527B 347B 3.61B 3.17B 2.95B 2.7B 5.08B 5.16B 34.97B 13.66B 171B 13.54B 13.24B 590B
Net income 41.51B 431M 379M 352M 323M 607M 616M 4.18B 1.63B 20.41B 1.62B 1.58B 70.56B 51.52B 535M 470M 437M 401M 753M 765M 5.19B 2.03B 25.33B 2.01B 1.97B 87.58B
Net Debt -106B -1.1B -968M -900M -826M -1.55B -1.58B -10.68B -4.17B -52.15B -4.14B -4.05B -180B -131B -1.36B -1.2B -1.11B -1.02B -1.92B -1.95B -13.24B -5.17B -64.62B -5.12B -5.01B -223B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
27/07/26 1,409.40 -0.09% 1,162,030
24/07/26 ₹1,410.60 +1.26% 2,917,791
23/07/26 ₹1,393.00 -1.56% 4,248,433
22/07/26 ₹1,415.10 -1.21% 1,722,239
21/07/26 ₹1,432.50 -0.63% 1,341,452
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,410.60INR
Average target price
1,513.00INR
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock